Evolutionary Therapy for Rhabdomyosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan Metts, MD
Moffitt Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Children'S Hospital of Colorado
Aurora, Colorado, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami - Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
- Montefiore Medical Cancer Center
The Bronx, New York, United States
- University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Carolinas Medical Center, Levine Cancer Institute
Charlotte, North Carolina, United States
- Duke Children'S Hospital
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Vanderbilt - Ingram Cancer Center
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Md Anderson
Houston, Texas, United States
- Primary Children'S Medical Center/utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Dec 2020
- Primary completion
- 31 Aug 2026
- Completion
- 31 Aug 2027
- Last update posted
- 26 Nov 2025
- Registered enrollment
- 12
- Registry id
- NCT04388839
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.